Edward Robins

Edward Robins is an accomplished professional in radiochemistry and imaging with extensive experience in leadership roles within the field. Currently serving as the Head of Radiopharmaceutical Research & Development at SAHMRI since November 2022, Robins has previously held key positions such as Deputy Director and Senior Principal Investigator at A*STAR Institute of Bioengineering & Bioimaging and Head of Radiochemistry at both the NUS Yong Loo Lin School of Medicine and Singapore Bioimaging Consortium. Robins has significant expertise in developing PET and SPECT radiochemistry methods and has led research teams at GE Healthcare. Robins holds a PhD in Chemistry from the University of Bristol and a BSc in Chemistry from Newcastle University.